Better Context → Better Decisions
Context counts in life sciences. The FENIX analyst team is tirelessly using its experience to put you in a position to succeed. Below, our readers with corporate access will find a wealth of contextualized life science insight ready to be viewed in the FENIX Marketplace.
Welcome to FENIX Syndicated Services. If you already have an account, please log in. If you have any questions or would like to subscribe to our services, please contact us.
$599
Posted in: Dual/triple agonist Aug 05 | 2019Final Tirzepatide Pivotal Trial Initiated (SURPASS-5 add-on to basal insulin)Purchase Blast
$599
Posted in: GLP-1RA, Glucose Monitoring Aug 01 | 2019ADA Standards of Care Update: REWIND, CGM TIR Targets, and Victoza PedsPurchase Blast
$599
Posted in: SGLT2i Jul 31 | 2019Lexicon Comments on Partnership Termination; Lexicon Q2 '19 Earnings UpdatePurchase Blast
$599
Posted in: Basal Insulin, Bolus Insulin, DPP-IVi, Dual/triple agonist, GLP-1RA, Glucagon, SGLT2i Jul 30 | 2019Empa T1DM Filed with FDA; Oral GLP-1RA Advanced to Ph1; Lilly Q2 '19 Earnings UpdatePurchase Blast
$599
Posted in: Basal Insulin, Bolus Insulin, GLP-1RA, GLP-1RA + Basal, SGLT2i Jul 29 | 2019Sanofi Q2 '19 Earnings UpdatePurchase Blast
$599
Posted in: GLP-1RA, SGLT2i Jul 26 | 2019Sanofi Terminates Partnership with Lexicon for Sotagliflozin DevelopmentPurchase Blast
$599
Posted in: Basal Insulin, Bolus Insulin Jul 26 | 2019Biocon CY Q2 '19 (FY Q1 '20) Earnings UpdatePurchase Blast
$599
Posted in: Glucagon Jul 26 | 2019FENIX Analysis: Baqsimi, Lilly’s Novel Nasal Glucagon Hypo Rescue ProductPurchase Blast
$599
Posted in: DPP-IVi, GLP-1RA, SGLT2i Jul 25 | 2019DECLARE Approval Timeline Moved Up; AZ Q2 '19 Earnings UpdatePurchase Blast
$599
Posted in: Glucose Monitoring, Other Jul 23 | 2019Is Glooko Eying an IPO? New Partnership with Pack Health for Patient CoachingPurchase Blast
$599
Posted in: Glucose Monitoring, Insulin Delivery Jul 23 | 2019Medtronic Files CGM for Non-Adjunctive ClaimPurchase Blast
$599
Posted in: Bolus Insulin, DPP-IVi, GLP-1RA, Glucagon Jul 22 | 2019REWIND CHMP Decision This Week; CHMP Agenda HighlightsPurchase Blast